A Lesson from McKesson: How Specialty Pharmacy Growth Is Hurting Wholesalers
Last week, McKesson released its quarterly earnings for the fourth calendar quarter of 2017. See the links below. The profit outlook for its distribution business was lower than Wall Street’s expectations, due partly to what management termed “customer and product mix.”
